The heart in Anderson-Fabry disease and other lysosomal storage disorders.
about
Multimodality Imaging for Left Ventricular Hypertrophy Severity Grading: A Methodological Review.Study of urinary proteomes in Anderson-Fabry disease.Rag GTPases are cardioprotective by regulating lysosomal function.Genetic screening of Fabry patients with EcoTILLING and HRM technology.Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease.Advanced Anderson-Fabry disease presenting with left ventricular apical aneurysm and ventricular tachycardia.Electrocardiographic Characterization of Cardiac Hypertrophy in Mice that Overexpress the ErbB2 Receptor Tyrosine Kinase.Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years' treatment.The Large Phenotypic Spectrum of Fabry Disease Requires Graduated Diagnosis and Personalized Therapy: A Meta-Analysis Can Help to Differentiate Missense MutationsMimics of Hypertrophic Cardiomyopathy - Diagnostic Clues to Aid Early Identification of Phenocopies.Effects of switching from agalsidase Beta to agalsidase alfa in 10 patients with anderson-fabry diseaseFabry disease in children and the effects of enzyme replacement treatment.Fabry disease: a review of current management strategies.Effects of enzyme replacement therapy in Fabry disease--a comprehensive review of the medical literature.Lysosomal lipid storage diseases.Left ventricular noncompaction in a patient with fabry disease: overdiagnosis, morphological manifestation of fabry disease or two unrelated rare conditions in the same patient?Fabry disease, enzyme replacement therapy and the significance of antibody responses.Genetics and metabolic cardiomyopathies.Current applications of biomarkers in cardiomyopathies.Fabry's disease: an example of cardiorenal syndrome type 5.Auditing the frequency and the clinical and economic impact of testing for Fabry disease in patients under the age of 70 with a stroke admitted to Saint Vincent's University Hospital over a 6-month period.Clinical and genetic predictors of major cardiac events in patients with Anderson-Fabry Disease.Fabry's disease with LVOT obstruction: diagnosis and management.Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies.Incidence and predictors of anti-bradycardia pacing in patients with Anderson-Fabry disease.Effect of enzyme replacement therapy on serum asymmetric dimethylarginine levels, coronary flow reserve and left ventricular hypertrophy in patients with Fabry disease.Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies.Rags to riches: Amino acid sensing by the Rag GTPases in health and disease.Prevalence of Fabry disease in male patients with unexplained left ventricular hypertrophy in primary cardiology practice: prospective Fabry cardiomyopathy screening study (FACSS).Rare Diseases: Drug Discovery and Informatics Resource.Anderson-Fabry disease: long-term echocardiographic follow-up under enzyme replacement therapy.Cardiac manifestations of Anderson-Fabry disease in children and adolescents.E-Learning for Rare Diseases: An Example Using Fabry Disease.Restrictive Cardiomyopathies: The Importance of Noninvasive Cardiac Imaging Modalities in Diagnosis and Treatment-A Systematic Review.Cardiac disease in children and young adults with various lysosomal storage diseases: Comparison of echocardiographic and ECG changes among clinical groups.Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases.Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women.Role of cardiac MRI in evaluating patients with Anderson-Fabry disease: assessing cardiac effects of long-term enzyme replacement therapy.Cardiac Phenotype of Prehypertrophic Fabry Disease.Anderson-Fabry disease in heart failure
P2860
Q30365700-2B225CC0-0EC9-4026-9BB8-0CECAE2CEB2FQ33721228-EC5E8FF2-8EAF-4F92-9B8F-016898A5C336Q33908036-A9C481A4-0E9C-4828-B0A5-130415D43D4CQ34012395-EE0CB1D7-4F65-4208-8ACA-045243F9EF9BQ35571515-FF1E18EB-9FDF-4818-A28A-02A11F7E0911Q35746687-3866656C-0585-46AF-AC7B-922B1E4B0ECDQ35996464-10192A08-FB20-45FD-9DB1-C6288D621574Q36105190-AD0970F3-B3D8-4311-AEF3-489BF69BA272Q36213022-78410829-EE1E-419B-9020-F36BF4CC706FQ36458794-727A4ECB-6769-4287-A577-D8DF34CEE6B7Q36590934-4783BBFA-0632-4F45-A1AC-FBA05951996DQ37350401-2878B361-579D-4094-8CD7-E984BCD44869Q37775790-A7A5398A-6A5D-4506-B066-0CC739E3DE0CQ37801828-81618FBF-F7FE-4EF3-8A2B-47755C4E2FBAQ37866549-810B6E57-B6B1-4F2E-8850-4B8F764A84E4Q37939529-9EA75D3B-0D3C-4931-95CC-E755D21801E8Q37950838-68739D5F-8FE3-45DD-874A-EDE439320325Q38039376-3822DFFE-D802-42B3-8636-7FBCD728428EQ38536678-CC435B5A-83D0-4F46-BEC1-10ABF2901EA2Q38558725-1787D2DD-0CBE-4675-94F5-5CA537AC326FQ38687892-43C76F80-C124-4DE1-AE49-B501DFBD7182Q39042794-42C13B2F-BF60-4C97-9D4D-A3D3C1EAEEF1Q39221352-56E4BA73-8864-4519-86C6-67F619F7BE74Q39347577-189E55F3-5DF8-4798-BA7C-DE956A1CF92FQ39715709-BF1CE96A-B5B7-4271-9BF4-ABBB1A25E7A0Q41364439-B09DC561-DE73-4D8B-899A-9DEBC2F68101Q41664792-4A40C3E8-2262-4A32-B45A-D6166CDC2E1FQ41968373-AA41A892-670D-4220-A5B3-1F11153C8E7EQ44282646-887F0091-FC57-47F3-825F-BA20E2D69342Q45873887-78678154-B31D-4C5F-8016-7028D089DCA0Q46587509-4C2EE9E9-6383-489D-A7C5-0C2779913E81Q46684439-0548AB4E-A2F5-4239-9A75-50657F8633A7Q47147113-7D5753C1-740B-4F33-80F8-5D712D2162C4Q47162150-BDE4BF26-CB44-466A-91B6-78EB0CCEC03FQ49954398-AF9A3CB6-8F45-44D7-BEBB-9AC344ED2676Q50499373-74C6D337-8BFC-4B0F-AF93-FB6A93596A25Q51563942-1CA4E60F-FE78-4FBE-9990-C5D6860A2E0FQ53086538-E488932A-F0D1-4843-886C-A41B1953B966Q55689337-3B9BBB11-2220-4D8D-861B-9C38FAD7A174Q56807662-D1C8F780-2FBC-42B6-8A60-02C04787B0C7
P2860
The heart in Anderson-Fabry disease and other lysosomal storage disorders.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The heart in Anderson-Fabry disease and other lysosomal storage disorders.
@ast
The heart in Anderson-Fabry disease and other lysosomal storage disorders.
@en
type
label
The heart in Anderson-Fabry disease and other lysosomal storage disorders.
@ast
The heart in Anderson-Fabry disease and other lysosomal storage disorders.
@en
prefLabel
The heart in Anderson-Fabry disease and other lysosomal storage disorders.
@ast
The heart in Anderson-Fabry disease and other lysosomal storage disorders.
@en
P2860
P356
P1433
P1476
The heart in Anderson-Fabry disease and other lysosomal storage disorders
@en
P2093
Perry M Elliott
P2860
P304
P356
10.1136/HRT.2005.063818
P407
P50
P577
2007-04-01T00:00:00Z